GlobeNewswire by notified

BW Offshore: Fourth quarter and full-year results 2022


Fourth quarter and full-year results 2022


  • Q4 EBITDA of USD 104.9 million and operating cash flow of USD 174.7 million
  • 2022 EBITDA of USD of 345.7 million and operating cash flow of USD 650.3 million
  • Equity ratio of 32.9% and USD 371.0 million in available liquidity at end of 2022
  • Cash dividend of USD 0.035 per share equivalent to USD 6 million and BW Energy shares as in-kind distribution of USD 5 million for the quarter
  • Distributed USD 25.3 million in cash dividends and USD 13.6 million worth of BW Energy Limited shares as dividend in-kind in 2022
  • Barossa FPSO project progress at 58% per end of January 2023
  • Repurchased USD 60.6 million of Senior Unsecured Convertible Bonds in 2022
  • Contract extensions signed for Sendje Berge and Abo FPSO
  • Divestment of FPSO BW Joko Tole, BW Cidade de São Vicente, FPSO Umuroa, FPSO Polvo and hand-over of Yùum K’ak’ Náab

BW Offshore continues to progress the Barossa FPSO project with overall completion at 58% per end of January. The project has achieved 10.2 million manhours without injuries, which reflects BW Offshore and the project partners' commitment to safeguard people and operations. As per end of January, the Hull construction was at 78%, the Turret & Mooring System at 72%, while the Topsides construction stood at 50% completion.

"We focus on executing the Barossa project as per plan, safe and efficient operation of our core assets and concluding the divestment of our non-core units as a basis for continued stable shareholder distributions," said Marco Beenen, CEO of BW Offshore. "While we were disappointed that the Gato de Mato project was paused, it confirmed our ability to replicate infrastructure like FPSO projects with long-term contracts, investment grade counterparties and attractive partnership models. We continue to selectively progress new projects in a strong FPSO market environment.”

The Board of Directors has declared a cash dividend of USD 0.035 per share and USD 5 million of BW Energy Limited shares as in-kind distribution. Shares will trade ex-dividend from 2 March 2023. Shareholders recorded in VPS following the close of trading on Oslo Børs on 3 March 2023 will be entitled to the distribution payable on or about 10 March 2023.

EBITDA for the fourth quarter of 2022 was USD 104.9 million (USD 80.4 million in Q3 2022). The increase was mainly driven by reimbursement of expenses incurred related to Gato do Mato under the limited notice to proceed (LNTP) contract with Shell being recorded in Q4 as the project has been paused. Net positive impact from this being recorded in Q4 was USD 13.6 million. The result for Q4 was further supported by good fleet performance in the last quarter of the year.

EBIT for the fourth quarter was positive USD 37.8 million (positive USD 29.6 million in Q3 2022) and included an impairment of USD 15.8 million for earlier capitalised cost related to the Gato do Mato project.

Share of loss of equity-accounted investees was USD 2.0 million compared to a gain of USD 7.2 million the third quarter and includes BW Offshore’s share of net result from the ownership in BW Energy.

Tax expense for the fourth quarter was USD 3.0 million (USD 3.3 million in Q3 2022).

Total equity on 31 December 2022 was USD 1 151.1 million (USD 1 095.6 million in Q3 2022). The equity ratio was 32.9% at the end of the quarter (33.8% in Q3 2022).

Available liquidity on 31 December 2022 was USD 371.0 million, excluding consolidated cash from BW Ideol.

Consolidated net interest-bearing debt was USD 497.4 million (USD 463.2 million in Q3 2022).

During the quarter, the FPSO fleet continued to deliver stable uptime with a weighted average commercial uptime for the fleet of 99.1% (99.2% in Q3 2022).

The contract for Petróleo Nautipa reached the end of its term in October. The FPSO will be sold for recycling after completion of demobilisation and decommissioning.

In November 2022, the Company signed a six-month contract extension for the lease and operation of Sendje Berge, for which divestment negotiations are ongoing.

In January 2023, the contract for Abo FPSO was extended until the end of March 2023. The Company is engaged in divestment negotiations for the unit.

BW Offshore is actively engaged in the energy transition by developing clean energy production solutions, applying its offshore engineering and operations capabilities to drive future value creation through its 53.2% ownership in BW Ideol.

BW Ideol is a global leader in offshore floating wind technology and co-development with more than 12 years of experience from design, execution and development of floating wind projects based on proprietary and patented Damping Pool® technology and engineering capabilities.

In January, the Floatgen demonstrator reached 25 GWh accumulated production, with an annual availability of over 95%.

The Company expects that the core units in the existing fleet will continue to generate significant cash flow in the time ahead supported by the USD 6.0 billion firm contract backlog at year-end 2022 including the Barossa contract.

Nations are expected to increasingly prioritise energy security through diversification of sourcing. The attention to energy independence combined with higher prices, have incentivised oil and gas companies to progress new field development projects in the current inflationary environment.

BW Offshore experiences increased interest for infrastructure type lease and operate FPSO projects, combined with continued access to equity and debt financing for field development initiatives with long-term production, low break-even costs and low carbon emissions. There is also increased activity related to redeployment projects.

The Gato do Mato tender process reconfirmed BW Offshore’s ability to develop a robust execution plan and source the required equity and debt from high-quality investors and lenders. BW Offshore maintains a selective approach to such opportunities, progressing discussions on only a few high-end projects which can be developed in partnership with global infrastructure investors.

The ongoing asset divestment programme for the non-core FPSOs is expected to be completed in 2023 in line with strategy, reducing the operational risks associated with the conventional units and strengthening the balance sheet. The BW Opportunity is retained and marketed as a redeployment candidate.

BW Ideol is BW Offshore’s vehicle for investment in floating offshore wind. The company is progressing multiple projects in collaboration with BW Offshore and other partners.

BW Offshore’s is well positioned for future growth and long-term value creation through the execution of accretive offshore energy projects.

Please see attached the Annual Report and Q4 Presentation. The earnings tables are available at:

BW Offshore will host a conference call of the financial results 09:00 (CET) today. The presentation will be given by CEO Marco Beenen and CFO Ståle Andreassen.

Conference call information:
To dial in to the conference call where the fourth quarter results and Q&A will be hosted, please pre-register to the event call:

BW Offshore Limited - Q4 Call Registration

You can also follow the presentation via webcast with supporting slides and a Q&A module, available on:

BW Offshore Limited - Q4 Presentation Webcast

Please note, that if you follow the webcast via the above URL, you will experience a 30 second delay compared to the main conference call. The web page works best in an updated browser - Chrome is recommended.

For further information, please contact:
Ståle Andreassen, CFO, +47 91 71 86 55
Anders S. Platou, Head of Corporate Finance & Strategy, +47 99 50 47 40

About BW Offshore:
BW Offshore engineers innovative floating production solutions. The Company has a fleet of 10 FPSOs with potential and ambition to grow. By leveraging four decades of offshore operations and project execution, the Company creates tailored offshore energy solutions for evolving markets world-wide. BW Offshore has around 2,000 employees and is publicly listed on the Oslo stock exchange.

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.


To view this piece of content from, please give your consent at the top of this page.
To view this piece of content from, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Junshi Biosciences Announces Establishment of Joint Venture with Rxilient Biotech to Jointly Develop and Commercialize Toripalimab in Southeast Asia29.3.2023 05:39:38 CEST | Press release

-- The two parties will collaborate to develop and commercialize toripalimab in 9 Southeast Asian countries through a joint venture company, Excellmab -- Excellmab will be responsible for the development, medical affairs, production of finished products, and commercialization of toripalimab within the cooperation territory. The profits available for distribution by Excellmab will be distributed in proportion to the respective shareholdings of the parties -- Using the Excellmab platform, the two parties also plan to collaborate extensively to introduce more high-quality innovative drugs into Southeast Asian markets to achieve joint and long-term development -- According to the progress of toripalimab’s R&D and other projects, Junshi Biosciences may receive a milestone payment of up to approximately US$4.52 million, plus a certain percentage of royalties on net sales SHANGHAI, China and SINGAPORE, March 28, 2023 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Bioscience

Aduro Clean Technologies Increases Size of Private Placement to $4 Million29.3.2023 02:12:40 CEST | Press release

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES SARNIA, Ontario, March 28, 2023 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (CSE: ACT) (OTCQB: ACTHF) (FSE: 9D50), a Canadian developer of patented water-based technologies to chemically recycle plastics, and to transform heavy crude and renewable oils into feedstocks and higher-value fuels, is pleased to announce that, further to its news release dated March 8, 2023, it has increased the size of its non-brokered private placement of units (the “Units”) at $0.93 per Unit for gross proceeds of a minimum of $1,999,965 and up to a maximum of $4,000,000 (the “LIFE Offering”). Each Unit will consist of one (1) common share in the capital of the Company (each, a “Common Share”) and one-half (1/2) of one Common Share purchase warrant (each whole warrant, a “Warrant”). Each Warrant will be exercisable into one (1) Common Share (each, a “Warrant Share”) at a price o

ClearPoint Neuro Announces Exclusive Multi-Year Licensing Agreement with UCSF for Innovative Intra-Cerebral Cellular Delivery Platform28.3.2023 22:05:00 CEST | Press release

SOLANA BEACH, Calif., March 28, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced an exclusive multi-year licensing agreement of intellectual property from UC San Francisco (UCSF) through its Innovation Ventures group to develop and commercialize a radially branching cellular delivery device for use both in the Operating Room under fluoroscopy/CT guidance and under MRI guidance. “This invention will help clinicians guide the delivery of biologic therapies — from stem cell transplants to gene therapy vectors — to specific locations in the human brain with real-time image guidance,” said Dr. Daniel Lim, MD, PhD, Professor of Neurological Surgery at UCSF. “By helping surgeons tailor biologic delivery to individual patient anatomy and specific diseases, I hope that this invention can contribute importantly to the successful treatment of neurological disor

Development of the Annual General Meeting of the BANK of Greenland28.3.2023 22:03:19 CEST | Press release

Minutes of General Meeting To Nasdaq OMX Copenhagen 28 March 2022 Company announcement no. 05/2023 Development of the Annual General Meeting of the BANK of Greenland Today, the BANK of Greenland held its Annual General Meeting in accordance with the Articles of Association and the previously published notice convening the meeting. The Annual General Meeting was attended by shareholders representing 1,049,468 votes, of which 612,498 votes were given by proxy to the Board of Directors, 62,821 votes were covered by instructions to holders of power of attorney and 115,455 votes of correspondance. The Board of Directors' Report on the Bank's activities during the past year The Chairman of the Board of Directors Gunnar í Liða presented the Board of Directors' report on the Bank's activities during the past year. The report of the Board of Directors was noted. The Chairman's report can be viewed on the Bank's website at The minutes of the Annual General Meeting will also be pub

Forløb af ordinær generalforsamling i GrønlandsBANKEN28.3.2023 22:03:19 CEST | pressemeddelelse

Referat af Generalforsamling Til Nasdaq OMX Copenhagen 28. marts 2023 Selskabsmeddelelse nr. 05/2023 Forløb af ordinær generalforsamling i GrønlandsBANKEN GrønlandsBANKEN har i dag afholdt ordinær generalforsamling i henhold til vedtægterne og tidligere offentliggjort indkaldelse. Generalforsamlingen var repræsenteret med 1.049.468 stemmer, heraf var 612.498 stemmer givet som fuldmagt til bestyrelsen, 62.821 stemmer var givet som instruktionsfuldmagt, mens 115.455 var afgivet som brevstemme. Bestyrelsens beretning om bankens virksomhed i det forløbne år Bestyrelsesformand Gunnar í Liða aflagde bestyrelsens beretning om bankens virksomhed i det forløbne år. Bestyrelsens beretning blev taget til efterretning. Formandens beretning kan ses på bankens hjemmeside Generalforsamlingens protokollat vil senest 14 dage efter generalforsamlingens afholdelse ligeledes blive lagt på bankens hjemmeside. Godkendelse af årsrapporten for 2022, meddelelse om decharge for bestyrelse og direk